Communiqués OssDsign AB

Actions

OSSD

SE0012570448

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq Stockholm Autres places de cotation 14:30:54 15/06/2026			Varia. 5j.	Varia. 1 janv.
4,100 ^SEK	-0,97%		-4,85%	-63,67%

10/06	OssDsign AB (publ) élit Per Aniansson en qualité d'administrateur et de président du conseil	CI
09/06	Agenda du mardi 9 juin	FW

Communiqués

10/06	Annual General Meeting held in OssDsign AB	AQ
03/06	OssDsign AB announces updated proposal regarding board fees ahead of the annual general meeting 2026	AQ
06/05	OssDsign: Needs to prove slowdown is transitional – Q1 review	AQ
05/05	OssDsign: Full Q1 in line with profit warning	AQ
05/05	OssDsign AB (publ) publishes Q1 2026 interim report	AQ
28/04	OssDsign publishes Annual Report 2025	AQ
10/04	OssDsign: Preliminary Q1 figures reflect weak performance	AQ
10/04	OssDsign provides pre-release update on Q1 2026 performance	AQ
03/02	OssDsign: Sales slightly below but there are bright spots – Q4 initial	AQ
03/02	OssDsign AB (publ) publishes year-end report 2025	AQ
22/01	OssDsign: Sequential pick-up in organic momentum – Q4 preview	AQ
10/12	OssDsign: Mark Waugh appointed CEO	AQ
10/12	OssDsign appoints Mark Waugh as new CEO	AQ
04/11	OssDsign: A small bump on a long road – Q3 review	AQ
04/11	OssDsign Q3 25 - Interview	AQ
04/11	OssDsign AB (publ) publishes Q3 2025 interim report	AQ
15/10/25	OssDsign: Tough comparison but robust underlying – Q3 preview	AQ
20/08/25	OssDsign Q2 - Strong sales but higher costs ahead	AQ
20/08/25	OssDsign: Another quarter, another step forward – Q2 review	AQ
19/08/25	OssDsign AB (publ) publishes Q2 2025 interim report	AQ
06/08/25	OssDsign: FX headwinds but solid underlying momentum – Q2 preview	AQ
01/07/25	Exercise period starts in OssDsign's long-term incentive warrant program 2022/2025, boosting the company's cash position by up to SEK 10 million	AQ
27/06/25	OssDsign - First PROPEL data looks strong	AQ
27/06/25	OssDsign: Strong data from PROPEL 12-month follow-up	AQ
26/06/25	OssDsign announces remarkable real-world results with 88.4% fusion rate in a highly complex patient cohort from the spinal fusion registry PROPEL	AQ